WOOREE BIO Co., Ltd. (KRX: 082850) is a South Korea-based biotechnology and electronic components manufacturer that develops, produces, and commercializes health functional foods, natural bioactive ingredients, and precision display materials. Founded in May 2000 and headquartered in Ansan-si, Gyeonggi-do, South Korea, the company operates within the Wooree Group alongside affiliates including Wooree Lighting, Wooree E&L, and Wooree Enterprise. The company conducts business across two primary segments: the Bio Division and the Electronics Division. Within its Bio Division, the company provides end-to-end original equipment manufacturing (OEM) and original design manufacturing (ODM) solutions for dietary supplements and nutraceuticals, managing raw material synthesis, formulation development, and finished product packaging under GMP and HACCP certifications; product dosage forms include softgels, hard capsules, tablets, powders, liquids, and stick pouches; proprietary finished consumer health products under brands such as CLARION; and botanical raw materials cultivated in smart vertical plant factories equipped with proprietary LED agricultural lighting systems, supporting commercial extraction of standardized plant compounds and advanced research into medical cannabis and cannabidiol (CBD) formulations. Within its Electronics Division, stemming from its foundational operations as Wooree ETI Co., Ltd. prior to its rebranding in March 2019, the company manufactures flexible printed circuit boards (FPCBs) for mobile devices and flat-panel displays; light-emitting diode (LED) packages and modules; backlight units (BLUs) for liquid-crystal display (LCD) monitors and televisions; and separator components for secondary battery applications. The company distributes its products to commercial clients and consumer markets across South Korea and global export destinations. In recent developments, the company completed a five-to-one share consolidation in September 2026 to optimize its capital structure and enhance trading stability on the KOSDAQ market. In addition, the company expanded its commercial nutraceutical portfolio with the launch of its CLARION brand in late 2025, deploying a line of targeted health supplements, while continuing to advance vertical integration and smart-farm extraction partnerships within the Wooree Group to accelerate the commercialization of high-purity natural functional ingredients and active pharmaceutical materials.